Cerebral small-vessel disease and progression of brain atrophy The SMART-MR study

被引:81
|
作者
Kloppenborg, R. P. [1 ,4 ]
Nederkoorn, P. J. [4 ]
Grool, A. M. [1 ]
Vincken, K. L. [2 ]
Mali, W. P. T. M. [3 ]
Vermeulen, M. [4 ]
van der Graaf, Y. [1 ]
Geerlings, M. I. [1 ]
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands
关键词
WHITE-MATTER LESIONS; COGNITIVE DECLINE; HIPPOCAMPAL ATROPHY; RISK-FACTORS; FOLLOW-UP; RATES; LACUNES; VOLUMES; LADIS; AD;
D O I
10.1212/WNL.0b013e3182749f02
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To investigate whether severity and progression of periventricular and deep white matter lesions (WML) and lacunar infarcts were associated with progression of brain atrophy. Methods: Within the SMART-MR study, a prospective cohort on MRI changes in patients with symptomatic atherosclerotic disease, 565 patients (57 +/- 9 years) without large infarcts had vascular screening and 1.5 T MRI at baseline and after a mean follow-up of 3.9 years. With automated brain segmentation, total brain, cortical gray matter, ventricular, and WML volumes were estimated and expressed relative to intracranial volume (%). Lacunar infarcts were rated manually. Results: Using linear regression analyses adjusted for demographics and vascular risk factors, periventricular WML volume at baseline was associated with greater decrease in cortical gray matter volume (B = -1.73%, 95% confidence interval [CI] -3.15% to -0.30%, per 1% WML volume increase) and greater increase in ventricular volume (B = 0.12%, 95% CI 0.04% to 0.20%). Progression of periventricular WML volume corresponded with a greater decrease in cortical gray matter volume (B = -0.45%, 95% CI -0.9% to 0%) and greater increase in ventricular volume (B = 0.15%, 95% CI 0.1% to 0.2%). Presence of lacunar infarcts was associated with greater decline in total brain volume (B = -0.25%, 95% CI -0.49% to -0.01%) and progression of lacunar infarcts with a greater decrease of total brain (B = -0.30%, 95% CI -0.59% to 0.01%) and cortical gray matter volume (B = -0.81%, 95% CI -1.43% to -0.20%). Conclusions: In patients with symptomatic atherosclerotic disease, presence and progression of periventricular WML and lacunar infarcts is associated with greater progression of brain atrophy independent of vascular risk factors. Neurology (R) 2012; 79: 2029-2036
引用
收藏
页码:2029 / 2036
页数:8
相关论文
共 50 条
  • [1] Homocysteine and progression of generalized small-vessel disease The SMART-MR Study
    Kloppenborg, Raoul P.
    Geerlings, Mirjam I.
    Visseren, Frank L.
    Mali, Willem P. T. M.
    Vermeulen, M.
    van der Graaf, Yolanda
    Nederkoorn, Paul J.
    NEUROLOGY, 2014, 82 (09) : 777 - 783
  • [2] Homocysteine, kidney function and progression of cerebral small vessel disease. The SMART-MR study
    Kloppenborg, R. P.
    Geerlings, M. I.
    Visseren, F. L.
    Vermeulen, M.
    van der Graaf, Y.
    Nederkoorn, P. J.
    CEREBROVASCULAR DISEASES, 2013, 35 : 37 - 38
  • [3] Carotid Atherosclerosis and Progression of Brain Atrophy: The SMART-MR Study
    Muller, Majon
    van der Graaf, Yolanda
    Algra, Ale
    Hendrikse, Jeroen
    Mali, Willem P.
    Geerlings, Mirjam I.
    ANNALS OF NEUROLOGY, 2011, 70 (02) : 237 - 244
  • [4] Blood Pressure and Progression of Brain Atrophy The SMART-MR Study
    Jochemsen, Hadassa M.
    Muller, Majon
    Visseren, Frank L.
    Scheltens, Philip
    Vincken, Koen L.
    Mali, Willem P.
    van der Graaf, Yolanda
    Geerlings, Mirjam I.
    JAMA NEUROLOGY, 2013, 70 (08) : 1046 - 1053
  • [5] Reduced parenchymal cerebral blood flow is associated with greater progression of brain atrophy: The SMART-MR study
    Ghaznawi, Rashid
    Zwartbol, Maarten H. T.
    Zuithoff, Nicolaas P. A.
    de Bresser, Jeroen
    Hendrikse, Jeroen
    Geerlings, Mirjam, I
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (06): : 1229 - 1239
  • [6] Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study
    Kloppenborg, Raoul P.
    Nederkoorn, Paul J.
    van der Graaf, Yolanda
    Geerlings, Mirjam I.
    ATHEROSCLEROSIS, 2011, 216 (02) : 461 - 466
  • [7] Carotid Artery Stenosis and Progression of Hemispheric Brain Atrophy: The SMART-MR Study
    Ghaznawi, Rashid
    Rissanen, Ina
    de Bresser, Jeroen
    Kuijf, Hugo J.
    Zuithoff, Nicolaas P. A.
    Hendrikse, Jeroen
    Geerlings, Mirjam, I
    CEREBROVASCULAR DISEASES, 2023, 52 (02) : 226 - 233
  • [8] Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: The Second Manifestations of ARTerial disease (SMART)-Medea study
    Grool, A. M.
    van der Graaf, Y.
    Mali, W. P. Th M.
    Witkamp, Th. D.
    Vincken, K. L.
    Geerlings, M. I.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (02) : 359 - 370
  • [9] Relation of cerebral small-vessel disease and brain atrophy to mild parkinsonism in the elderly
    Reitz, Christiane
    Trenkwalder, Claudia
    Kretzschmar, Konrad
    Roesler, Andreas
    von Eckardstein, Arnold
    Berger, Klaus
    MOVEMENT DISORDERS, 2006, 21 (11) : 1914 - 1919
  • [10] Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study
    Kooistra, Minke
    Geerlings, Mirjam I.
    Mali, Willem P. T. M.
    Vincken, Koen L.
    van der Graaf, Yolanda
    Biessels, Geert Jan
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 332 (1-2) : 69 - 74